Ovarian Cancer

Introductory Remarks & Presentation of the SOLO1 trial (webcasts below):

NEJM: Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer

K. Moore and Others

DOI: 10.1056/NEJMoa1810858 | October 21, 2018